13th International Conference on Alzheimer's Drug Discovery
10th September 2012 — 11th September 2012

A two-day global conference for research scientists to engage in discussion and cross fertilization of ideas focusing on Alzheimer’s drug discovery research.

The conference objectives are to: (1) discuss scientific progress on drug discovery programs aimed at treating Alzheimer’s disease and related dementias; and (2) increase networking opportunities for scientists to share information and resources. The meeting attracts about 150 academic, industry and government scientists from around the world.

ABOUT THIS MEETING

This annual Alzheimer's Drug Discovery Foundation (ADDF) conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias.

The ADDF’s funded investigators and top level scientists in the field will present on their current research progress and stimulate discussion. The conference offers ample opportunities for collaboration and partnering.

OBJECTIVES

●  Highlight scientific progress on drug discovery programs aimed at treating Alzheimer’s disease and related dementias.

●  Increase networking opportunities for scientists to share information and resources.

●  Foster interdisciplinary and public-private partnerships and alliances.

TARGET AUDIENCE

The 2011 edition of this conference attracted attendees from around the world.  Attendees included:

●  Academic and industry scientists engaged in drug discovery research for neurodegenerative diseases and CNS

●  Business development and licensing professionals

●  Alliance management professionals

●  Venture capitalists and other investors

Expected Number of Attendees

MA

View Conference Website: 13th International Conference on Alzheimer's Drug Discovery

Price of Attendance

N/A

Brochure

View Event Brochure

Location

Hyatt Regency
Jersey City
New Jersey
United States
NJ 07302